Guangxi LiuYao Group Co., Ltd. (603368.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 15.25

From 52W high−22.50%

Volume1.95M

Market capCNY 6.25B

P/E (TTM)8.8x

P/S (TTM)0.3x

Div yield4.42%

Key dataSep 18, 2026

Open

CNY 15.25

From 52W high

−22.50%

Volume

1.95M

Market cap

CNY 6.25B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.1x

P/E (TTM)

8.8x

RSI (14)

42.8

MomentumView details →

1D Return

−0.88%

YTD Return

−13.75%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

8.8x

EV/EBITDA

8.1x

EV/Sales

0.4x

P/S (TTM)

0.3x

P/B (TTM)

0.8x

ProfitabilityView details →

Gross Margin

10.93%

Net Margin

3.13%

EBITDA Margin

4.79%

ROE (TTM)

8.20%

ROA (TTM)

3.15%

Asset Turnover

1.00x

GrowthView details →

Revenue YoY

+1.26%

EPS YoY

−19.72%

FCF YoY

+31.50%

Revenue CAGR 3Y

+3.18%

EPS CAGR 3Y

−2.65%

EBITDA YoY

—

MomentumView details →

1D Return

−0.88%

YTD Return

−13.75%

1Y Return

−24.32%

RSI (14)

42.8

vs 50D SMA

−2.36%

vs 200D SMA

−8.54%

Capital & dividendView details →

Debt/Equity

0.50x

Current Ratio

1.60x

Quick Ratio

1.30x

Div Yield

4.42%

Div Rate

CNY 0.68

Div Growth 1Y

−9.45%

EarningsView details →

EPS (Actual)

CNY 0.36

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−1.06%

Financials snapshotView financials →

Revenue (TTM)

20.99B

Net Income (TTM)

656.72M

Op. CF (TTM)

1.09B

Next earningsOct 22, 2026 →

Latest newsMore news →

Liuzhou Pharmaceutical Group announced its first-half 2026 results: revenue of 10.526 billion yuan, up 2.19% year-on-year, and net profit attributable to shareholders of 369 million yuan, down 14.00% year-on-year.19d ago

Similar companies

南京医药600713.SH Medlive Technology Co., Ltd.02192.HK Henry Schein, Inc.HSIC Guardian Pharmacy Services, Inc.GRDN 中国医药600056.SH Guanze Medical Information Industry (Holding) Co., Ltd.02427.HK Find similar companies →

Latest newsMore news →

Liuzhou Pharmaceutical Group announced its first-half 2026 results: revenue of 10.526 billion yuan, up 2.19% year-on-year, and net profit attributable to shareholders of 369 million yuan, down 14.00% year-on-year.19d ago